Collegium Pharmaceutical, Inc. (COLL)
USD 26.73
(1.63%)
USD 26.73
(1.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 566.76 Million | 463.93 Million | 276.86 Million | 310.01 Million | 296.7 Million | 280.41 Million |
| Cost of Revenue | 240.59 Million | 254.44 Million | 126.25 Million | 130.18 Million | 193.66 Million | 165.67 Million |
| Gross Profit | 326.16 Million | 209.48 Million | 150.61 Million | 179.83 Million | 103.04 Million | 114.73 Million |
| Operating Expenses | 159.2 Million | 176.16 Million | 128.41 Million | 123.6 Million | 126.78 Million | 135.42 Million |
| Selling, General and Administrative Expenses | 159.2 Million | 172.18 Million | 118.96 Million | 113.83 Million | 116.44 Million | 126.76 Million |
| Research and Development Expenses | - | 3.98 Million | 9.45 Million | 9.77 Million | 10.34 Million | 8.66 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 399.8 Million | 430.61 Million | 254.66 Million | 253.78 Million | 320.44 Million | 301.09 Million |
| Operating Income | 166.96 Million | -104.57 Million | -46.69 Million | -5.08 Million | -23.74 Million | -20.68 Million |
| Interest Expense | 83.33 Million | 63.21 Million | 21.01 Million | 28.88 Million | 909 Thousand | 20.13 Million |
| Income Tax Expense | 27.57 Million | -3.84 Million | -74.89 Million | 830 Thousand | -14.57 Million | -110.9 Million |
| Earnings before Tax | 75.73 Million | -28.84 Million | -3.37 Million | 27.58 Million | -22.72 Million | -39.12 Million |
| Net Income | 48.15 Million | -25 Million | 71.51 Million | 26.75 Million | -8.14 Million | -39.12 Million |
| Earnings Per Share Basic | 1.60 | -0.74 | 2.05 | 0.78 | -0.24 | -1.19 |
| Earnings Per Share Diluted | 1.29 | -0.74 | 1.86 | 0.76 | -0.24 | -1.19 |
| Weighted Average Shares Outstanding | 33.74 Million | 33.82 Million | 34.93 Million | 34.4 Million | 33.45 Million | 32.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 41.78 Million | 33.82 Million | 41.04 Million | 35.15 Million | 33.45 Million | 32.95 Million |
| Gross Margin | 0.58 | 0.45 | 0.54 | 0.58 | 0.35 | 0.41 |
| EBIT Margin | 0.54 | 0.07 | 0.08 | 0.18 | -0.07 | -0.07 |
| Profit Margin | 0.08 | -0.05 | 0.26 | 0.09 | -0.03 | -0.14 |
| EBITDA | 308.32 Million | 168.75 Million | 86.57 Million | 118.07 Million | -6.01 Million | 91.91 Million |
| Earnings Before Tax Margin | 0.29 | -0.23 | -0.17 | -0.02 | -0.08 | -0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 145.27 Million | 144.92 Million | 566.76 Million | 149.74 Million | 136.7 Million | 135.54 Million |
| Cost of Revenue | 54.47 Million | 53.46 Million | 240.59 Million | 55.11 Million | 56.39 Million | 61.72 Million |
| Gross Profit | 90.8 Million | 91.45 Million | 326.16 Million | 94.63 Million | 80.31 Million | 73.82 Million |
| Operating Expenses | 43.33 Million | 41.98 Million | 159.2 Million | 32.94 Million | 35.29 Million | 38.19 Million |
| Selling, General and Administrative Expenses | 43.33 Million | 41.98 Million | - | 32.94 Million | 35.29 Million | 38.19 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 97.8 Million | 95.44 Million | 399.8 Million | 88.05 Million | 91.69 Million | 99.91 Million |
| Operating Income | 47.47 Million | 49.47 Million | 166.96 Million | 61.68 Million | 45.01 Million | 35.63 Million |
| Interest Expense | 15.58 Million | 17.33 Million | 83.33 Million | 19.28 Million | 20.76 Million | 21.86 Million |
| Income Tax Expense | 9.49 Million | 8.9 Million | 27.57 Million | 14.77 Million | 8.14 Million | 4.79 Million |
| Earnings before Tax | 29.09 Million | 36.62 Million | 75.73 Million | 46.71 Million | 28.78 Million | 17.79 Million |
| Net Income | 19.6 Million | 27.71 Million | 48.15 Million | 31.94 Million | 20.63 Million | 13 Million |
| Earnings Per Share Basic | 0.60 | 0.86 | - | 0.99 | 0.61 | 0.38 |
| Earnings Per Share Diluted | 0.52 | 0.71 | - | 0.82 | 0.53 | 0.34 |
| Weighted Average Shares Outstanding | 32.43 Million | 32.32 Million | 33.74 Million | 32.3 Million | 33.74 Million | 34.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.38 Million | 41.43 Million | 41.78 Million | 41.27 Million | 42.05 Million | 42.84 Million |
| Gross Margin | 0.63 | 0.63 | 0.58 | 0.63 | 0.59 | 0.54 |
| EBIT Margin | 0.57 | 0.59 | - | 0.68 | 0.63 | 0.58 |
| Profit Margin | 0.13 | 0.19 | 0.08 | 0.21 | 0.15 | 0.10 |
| EBITDA | 82.93 Million | 84.9 Million | - | 101.45 Million | 86.7 Million | 78.01 Million |
| Earnings Before Tax Margin | 0.33 | 0.34 | 0.29 | 0.41 | 0.33 | 0.26 |
MICEL
EDXC
002778
CFFS
603722
CMFO